Anvisa suspends sale and orders recall of Peptistrong supplement due to lack of safety assessment

➡️The measure was motivated by the disclosure and sale of the supplement without a prior safety assessment for the use of its main ingredient.

According to the resolution, evidence of advertising and marketing of the product containing Peptistrong hydrolyzed fava bean protein, an ingredient that had not undergone a health safety assessment for use in food, was identified.

The determination affects all batches of the product, which is under the responsibility of the company Manipulação Stevia Ltda., known as Biostevi Pharma.

In addition to ordering the recall, the agency suspended all stages related to the product, from manufacturing and distribution to sale, advertising and use.

The resolution cites health standards related to food safety and regularization as the basis for the measure. The decision came into force on the date of its publication.